Sun Pharma, Samsung BioLogics ink $55.5 mn pact
As per the pact, Sun Pharma has appointed Samsung BioLogics to manufacture Tildrakizumab.
Jul 04, 2017, 14:34 PM IST
As per the pact, Sun Pharma has appointed Samsung BioLogics to manufacture Tildrakizumab.
Jul 04, 2017, 14:34 PM IST